TARAMINO, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.008
EU - Europa 612
AS - Asia 251
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 1.918
Nazione #
US - Stati Uniti d'America 998
SE - Svezia 166
CN - Cina 143
IE - Irlanda 95
KR - Corea 67
FI - Finlandia 57
FR - Francia 54
IT - Italia 47
UA - Ucraina 46
DE - Germania 43
SN - Senegal 41
AT - Austria 34
GB - Regno Unito 29
PL - Polonia 20
VN - Vietnam 18
BE - Belgio 13
CA - Canada 10
JP - Giappone 10
IN - India 9
RU - Federazione Russa 5
EU - Europa 4
BR - Brasile 2
NL - Olanda 2
BD - Bangladesh 1
PT - Portogallo 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.918
Città #
Chandler 204
Beijing 104
Dublin 94
Ann Arbor 86
Houston 62
Jacksonville 46
Villeurbanne 43
Nyköping 41
Medford 37
Ashburn 34
Vienna 34
Princeton 30
Dearborn 27
Fairfield 24
Torino 22
Wilmington 21
Warsaw 20
Boardman 18
Fremont 15
Brussels 13
Woodbridge 13
Dong Ket 12
New York 12
Hangzhou 9
Pisa 8
Boston 7
Milan 7
Cambridge 6
Musashino 6
Norwalk 6
Seattle 6
Düsseldorf 5
Guangzhou 5
Verona 5
Des Moines 4
Falls Church 4
Indianapolis 4
Ottawa 4
Redwood City 4
Toronto 4
Washington 4
Fuzhou 3
Los Angeles 3
Mountain View 3
Pune 3
Chengdu 2
Kunming 2
Nanchang 2
Saint Petersburg 2
Shanghai 2
Venezia 2
Aachen 1
Baotou 1
Changsha 1
Dhaka 1
Gatineau 1
Groningen 1
Hamburg 1
Hefei 1
Istanbul 1
Lachine 1
Lourel 1
Mentana 1
Monmouth Junction 1
Munich 1
Nanjing 1
Philadelphia 1
Piraquara 1
Redmond 1
San Diego 1
San Jose 1
Shaoxing 1
Taipei 1
Tappahannock 1
Wenzhou 1
Xian 1
Yinchuan 1
Zhoushan 1
Totale 1.161
Nome #
Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast 134
Umbelliferone Aminoalkyl Derivatives asInhibitors of Human Oxidosqualene: Lanosterol Cyclase 90
Umbelliferone aminoalkyl derivatives as inhibitors of oxidosqualene cyclases from Saccharomyces cerevisiae, Trypanosoma cruzi and pneumocystis carinii 89
protein -protein interaction in sterol biosynthesis: the relationship between sterol-3-keto reductase and oxidosqualene cyclase 87
4-Methylzymosterone and Other Intermediates of Sterol Biosynthesis from Yeast Mutants Engineered in the ERG27 Gene Encoding 3-Ketosteroid Reductase 81
Exploring the access of the substrate to the active site of yeast oxidosqualene cyclase by site-directed mutagenesis 72
Oxidosqualene cyclase from Trypanosoma cruzi and Pneumocystis carinii expressed in Yeast: a model for the development of novel antiparasitic agents 72
Different interaction between oxidosqualene cyclase and steroid-3-ketoreductase from yeasts to mammals 72
Exploring the access of the substrate to the active site of yeast oxidosqualene cyclase by site-directed mutagenesis. 71
Inhibitory Effect of Umbelliferone Aminoalkyl Derivatives on Oxidosqualene Cyclases from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii, Homo sapiens and Arabidopsis thaliana: a structure-activity study 71
Design, Synthesis, and Biological Evaluation of New (2E,6E)-10-(Dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol Ethers as Inhibitors of Human and Trypanosoma cruzi Oxidosqualene Cyclase. 69
Access of the substrate to the active site of yeast oxidosqualene cyclase: an inhibition and site-directed mutagenesis appoach. 69
Characterization of the Channel Constriction Allowingthe Access of the Substrate to the Active Site of YeastOxidosqualene Cyclase 67
Oxidosqualene cyclase from Saccharomyces cerevisiae: a model for the development of novel antifungal and antiparasitic agents 66
Access of the substrate to the active site of yeast oxidosqualene cyclase: a modelling and site-directed mutagenesis approach 66
Characterization of a mutation that results in independence of oxidosqualene cyclase (Erg7) activity from a downstream 3-ketoreductase activity (Erg27) in the yeast ergosterol biosynthetic pathway 65
Access of the substrate to the active site of squalene and oxidosqualene cyclases: comparative inhibition, site-directed mutagenesis and homology-modelling studies. 64
Divergent interactions involving the oxidosqualene cyclase and thesteroid-3-ketoreductase in the sterol biosynthetic pathway ofmammals and yeasts 64
Different Interaction between Oxidosqualene Cyclase and Steroid-3-ketoreductase in Yeast and Mammals 62
Mutation analysis of the yeast 3-ketoreductase (Erg27p) and the effects on ergosterol biosynthesis 60
A mutation in yeast oxidosqualene cyclase (Erg7) makes it independent of 3-ketoreductase activity (Erg27) 60
The Interaction of 3-Keto Reductase and Oxidosqualene Cyclase, Two Key Enzymes in the Ergosterol Biosynthetic Pathway 59
Interaction of Steroid-3-Keto Reductase and Oxidosqualene Cyclase, Two Key Enzymes in the Ergosterol Biosynthetic Pathway 58
Genetic analyses involving interactions between the ergosterol biosynthetic enzymes, lanosterol synthase (Erg7p) and 3-ketoreductase (Erg27p), in the yeast Saccharomyces cerevisiae. 57
Interaction of oxidosqualene cyclase with C-4 sterol demethylation complex 55
Functional characterization by site-directed mutagenesis of human oxidosqualene cyclase (OSC) expressed in Pichia pastoris 55
Protein-protein interactions among ergosterol biosynthesis enzymes Erg7p/Erg27p and two-hybrid interactions involving Are1p and Are2p 53
Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents 53
Access of the substrate to the active site of yeast oxidosqualene cyclase: an inhibition and site-directed mutagenesis approach. 47
Totale 1.988
Categoria #
all - tutte 5.414
article - articoli 0
book - libri 0
conference - conferenze 3.124
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201957 0 0 0 0 0 0 0 0 0 0 40 17
2019/2020248 7 14 18 29 19 54 31 9 18 19 24 6
2020/2021240 35 7 15 18 29 9 11 4 43 10 25 34
2021/2022247 2 9 12 16 9 7 11 14 5 11 85 66
2022/2023479 46 47 6 59 49 132 39 32 37 3 20 9
2023/2024150 24 40 18 12 11 18 0 24 0 3 0 0
Totale 1.988